Discovery of novel natural products for mosquito control.


Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
21 Dec 2022
Historique:
received: 18 08 2022
accepted: 17 11 2022
entrez: 20 12 2022
pubmed: 21 12 2022
medline: 23 12 2022
Statut: epublish

Résumé

Vector control plays a key role in reducing the public health burden of mosquito-borne diseases. Today's vector control strategies largely rely on synthetic insecticides that can have a negative environmental impact when applied outdoors and often become inefficient because of the mosquitoes' ability to develop resistance. An alternative and promising approach to circumvent these challenges involves the implementation of insecticides derived from nature (biopesticides) for vector control. Biopesticides can constitute naturally occurring organisms or substances derived from them that have lifespan-shortening effects on disease vectors such as mosquitoes. Here we present the discovery and evaluation of natural product-based biological control agents that can potentially be developed into biopesticides for mosquito control. We screened a natural product collection comprising 390 compounds and initially identified 26 molecules with potential ability to kill the larval stages of the yellow fever mosquito Aedes aegypti, which is responsible for transmitting viruses such as dengue, Zika, chikungunya and yellow fever. Natural products identified as hits in the screen were further evaluated for their suitability for biopesticide development. We show that a selection of the natural product top hits, bactobolin, maytansine and ossamycin, also killed the larval stages of the malaria-transmitting mosquito Anopheles gambiae as well as the adult form of both species. We have further explored the usefulness of crude extracts and preparations from two of the best candidates' sources (organisms of origin) for mosquitocidal activity, that is extracts from the two bacteria Burkholderia thailandensis and Streptomyces hygroscopicus var. ossamyceticus.

Identifiants

pubmed: 36539851
doi: 10.1186/s13071-022-05594-z
pii: 10.1186/s13071-022-05594-z
pmc: PMC9768913
doi:

Substances chimiques

Biological Products 0
Biological Control Agents 0
Plant Extracts 0
Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI146398
Pays : United States
Organisme : NIH HHS
ID : R21AI146398
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

J Antibiot (Tokyo). 1980 Sep;33(9):1054-62
pubmed: 7440410
Trends Parasitol. 2016 Mar;32(3):187-196
pubmed: 26826784
J Travel Med. 2021 Dec 29;28(8):
pubmed: 34510205
Clin Cancer Res. 2014 Jan 1;20(1):15-20
pubmed: 24135146
Pest Manag Sci. 2019 Sep;75(9):2325-2340
pubmed: 30941861
PLoS One. 2018 Nov 6;13(11):e0206982
pubmed: 30399167
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14766-71
pubmed: 11121076
Food Chem Toxicol. 2021 Jan;147:111899
pubmed: 33279675
Org Lett. 2011 Jun 17;13(12):3048-51
pubmed: 21615115
Comput Biol Med. 2022 Jul;146:105535
pubmed: 35487124
Mol Ther Oncolytics. 2021 Sep 03;23:82-95
pubmed: 34703878
Nat Biotechnol. 2008 Oct;26(10):1077-83
pubmed: 18846070
J Pharmacobiodyn. 1980 Mar;3(3):177-82
pubmed: 7205539
Parasit Vectors. 2018 Dec 29;11(1):673
pubmed: 30594214
FEBS Lett. 1986 Oct 20;207(1):79-83
pubmed: 2876917
J Am Mosq Control Assoc. 2007;23(2 Suppl):133-63
pubmed: 17853604
Org Lett. 2010 Feb 19;12(4):716-9
pubmed: 20095633
Mem Inst Oswaldo Cruz. 2013 Nov;108(7):894-900
pubmed: 24037105
J Antibiot (Tokyo). 1965 Mar;18:82-8
pubmed: 14326088
J Am Mosq Control Assoc. 1987 Jun;3(2):302-3
pubmed: 3333059
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Molecules. 2020 Aug 31;25(17):
pubmed: 32878348
J Mol Biol. 2015 Feb 27;427(4):753-755
pubmed: 25562208
PLoS Negl Trop Dis. 2017 Jul 20;11(7):e0005625
pubmed: 28727779
J Bacteriol. 2009 Jun;191(12):3909-18
pubmed: 19376863
Afr J Tradit Complement Altern Med. 2014 Jun 04;11(4):84-8
pubmed: 25392586
Appl Environ Microbiol. 2020 May 19;86(11):
pubmed: 32220845
Evolution. 2005 Dec;59(12):2560-72
pubmed: 16526504
FEBS Lett. 1986 Jan 20;195(1-2):159-63
pubmed: 2867935
J Med Entomol. 2010 Nov;47(6):957-71
pubmed: 21175042
Philos Trans R Soc Lond B Biol Sci. 2011 Jul 12;366(1573):1987-98
pubmed: 21624919
J Antibiot (Tokyo). 1979 Oct;32(10):1069-71
pubmed: 528370
PLoS One. 2019 Apr 30;14(4):e0215958
pubmed: 31039188
Acta Trop. 2020 Jan;201:105179
pubmed: 31539525
Parasitol Res. 2011 Sep;109(3):715-26
pubmed: 21373809
J Am Chem Soc. 1972 Feb 23;94(4):1354-6
pubmed: 5062169
Curr Opin Insect Sci. 2020 Aug;40:111-116
pubmed: 32781416
Front Chem. 2021 Nov 15;9:779049
pubmed: 34869227
mBio. 2012 Dec 18;3(6):
pubmed: 23249812
Environ Sci Pollut Res Int. 2019 Feb;26(6):5514-5523
pubmed: 30610586
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):155-76
pubmed: 26739136
J Agric Food Chem. 2021 Sep 22;69(37):10830-10837
pubmed: 34496207
Sci Rep. 2018 Apr 18;8(1):6176
pubmed: 29670144
Sci Rep. 2018 May 29;8(1):8358
pubmed: 29844510
J Antibiot (Tokyo). 1996 Feb;49(2):162-7
pubmed: 8621357
Parasitol Res. 2008 Jul;103(2):325-31
pubmed: 18437424
Parasitol Res. 2016 May;115(5):1747-54
pubmed: 26932263
Pathogens. 2020 Jun 18;9(6):
pubmed: 32570965
PLoS Pathog. 2014 Oct 23;10(10):e1004398
pubmed: 25340821
Planta Med. 2021 Feb;87(1-02):6-23
pubmed: 33348409
Science. 1975 Sep 19;189(4207):1002-5
pubmed: 1241159
PLoS Negl Trop Dis. 2018 Apr 25;12(4):e0006443
pubmed: 29694346

Auteurs

Cecilia S Engdahl (CS)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Department of Clinical Microbiology, Virology, Umeå University, 90185, Umeå, Sweden.

Chinmay V Tikhe (CV)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

George Dimopoulos (G)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. gdimopo1@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH